Market capitalization | €486.24m |
Enterprise Value | €606.15m |
P/E (TTM) P/E ratio | 33.36 |
EV/FCF (TTM) EV/FCF | 24.67 |
EV/Sales (TTM) EV/Sales | 2.37 |
P/S ratio (TTM) P/S ratio | 1.90 |
P/B ratio (TTM) P/B ratio | 2.14 |
Dividend yield | 1.38% |
Last dividend (FY23) | €0.55 |
As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.
7 Analysts have issued a STRATEC forecast:
7 Analysts have issued a STRATEC forecast:
Jun '24 |
+/-
%
|
||
Revenue | 256 256 |
2%
2%
|
|
Gross Profit | 69 69 |
3%
3%
|
|
EBITDA | 45 45 |
1%
1%
|
EBIT (Operating Income) EBIT | 26 26 |
8%
8%
|
Net Profit | 15 15 |
23%
23%
|
In millions EUR.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
STRATEC SE engages in the design and manufacture of automated analyzer systems in the fields of clinical diagnostic and biotechnology. It operates through the following segments: Instrumentation, Diatron, Smart Consumables, and Other Activities. The Instrumentation segment consults, designs, develops and produces fully automated solutions for its partners in the fields of diagnostics including blood banking. The Diatron segment comprises the business with systems, system components, consumables and tests in the low throughput hematology and clinical chemistry segment. The Smart Consumables segment includes the business with developing and manufacturing smart consumables in the fields of diagnostics, life sciences, and medical technology. The Other Activities segment covers the development of work flow software for networking several analyzer systems and the development and sale of scientific materials and technologies. The company was founded by Hermann Leistner in 1979 and is headquartered in Birkenfeld, Germany.
Head office | Germany |
CEO | Marcus Wolfinger |
Employees | 1,522 |
Founded | 1979 |
Website | www.stratec.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.